⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30748946 | 0.89 | — | — | |
| SCHEMBL30748738 | 0.88 | HRH3 (0.33) | — | |
| SCHEMBL30748868 | 0.87 | — | — | |
| SCHEMBL31691343 | 0.79 | ACACB (0.34) | — | |
| SCHEMBL31691354 | 0.78 | AGXT (0.33) | — | |
| SCHEMBL30748939 | 0.78 | TRPV1 (0.33) | — | |
| SCHEMBL30748912 | 0.77 | GRM2 (0.34) | — | |
| SCHEMBL30748831 | 0.74 | HRH3 (0.36) | — | |
| SCHEMBL30748976 | 0.72 | SYK (0.36) | — | |
| SCHEMBL31691267 | 0.71 | BCL6 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304571-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) | 2025-10-02 | — | — | US | disclosed |
| EP-4565588-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | Suzhou Keen Therapeutics Co., Ltd. (CN) | 2025-06-11 | — | — | EP | disclosed |
| WO-2023241620-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) | 2023-12-21 | — | — | WO | disclosed |